SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-020633
Filing Date
2020-05-04
Accepted
2020-05-04 08:49:45
Documents
7
Period of Report
2020-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20200430.htm 8-K 37351
2 EX-1.1 sndx-ex11_8.htm EX-1.1 307900
3 EX-5.1 sndx-ex51_7.htm EX-5.1 14324
4 EX-99.1 sndx-ex991_9.htm EX-99.1 12585
5 GRAPHIC gij5l2gqlj4u000002.jpg GRAPHIC 28720
6 GRAPHIC gij5l2gqlj4u000001.jpg GRAPHIC 28720
7 GRAPHIC ge24ppjcbonx000001.jpg GRAPHIC 3505
  Complete submission text file 0001564590-20-020633.txt   457729
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 20842919
SIC: 2834 Pharmaceutical Preparations